Is the cost of research aimed at curing HIV worth it, when HIV can be effectively managed and prevented by existing drugs?

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday.

In clinical trials, researchers found Yeztugo to be highly effective as a twice-yearly form of pre-exposure prophylaxis.

This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.

The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah ...

As with many chronic and often deadly diseases, an ounce of prevention can be worth a ton of cure. It's a breakthrough drug for sure for those wanting to avoid HIV AIDS, but the price is eye popping.

A class of HIV drugs known as nucleotide reverse transcriptase inhibitors (NRTIs) may help prevent Alzheimer’s disease, reducing risk by up to 13%, a new study suggests.

A man has appeared in court to deny multiple counts of rape and intentionally transmitting HIV. Adam Hall, 42, of Donvale ...

The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to HIV-prevention infrastructure in the U.S.